GB0313064D0 - Mycobacterial vaccine - Google Patents

Mycobacterial vaccine

Info

Publication number
GB0313064D0
GB0313064D0 GBGB0313064.8A GB0313064A GB0313064D0 GB 0313064 D0 GB0313064 D0 GB 0313064D0 GB 0313064 A GB0313064 A GB 0313064A GB 0313064 D0 GB0313064 D0 GB 0313064D0
Authority
GB
United Kingdom
Prior art keywords
mycobacterial vaccine
mycobacterial
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0313064.8A
Other versions
GB2389364A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AgResearch Ltd
Original Assignee
AgResearch Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AgResearch Ltd filed Critical AgResearch Ltd
Publication of GB0313064D0 publication Critical patent/GB0313064D0/en
Publication of GB2389364A publication Critical patent/GB2389364A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB0313064A 2002-06-07 2003-06-06 Mycobacterial vaccines Withdrawn GB2389364A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ519395A NZ519395A (en) 2002-06-07 2002-06-07 Techniques for identifying genes that are important for virulence in Mycobacterial vaccines

Publications (2)

Publication Number Publication Date
GB0313064D0 true GB0313064D0 (en) 2003-07-09
GB2389364A GB2389364A (en) 2003-12-10

Family

ID=19928918

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0313064A Withdrawn GB2389364A (en) 2002-06-07 2003-06-06 Mycobacterial vaccines

Country Status (3)

Country Link
GB (1) GB2389364A (en)
IE (1) IE20030431A1 (en)
NZ (1) NZ519395A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008004247A1 (en) * 2006-07-06 2008-01-10 Rajesh Shah A novel medicinal formulation for inducing an immune response in patients with chronic and recurring infections
GB201008512D0 (en) 2010-05-21 2010-07-07 Health Prot Agency Mycobacterial antigen composition
US9663758B2 (en) * 2013-03-12 2017-05-30 Wisconsin Alumni Research Foundation Global gene regulators (GGR) as vaccine candidates against paratuberculosis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0991767A1 (en) * 1997-06-11 2000-04-12 Institut Pasteur Attenuated recombinant mycobacteria useful as immunogens or as vaccine components
US6136324A (en) * 1997-08-21 2000-10-24 Connaught Laboratories Limited Attenuated strains of mycobacteria
AU5559300A (en) * 1999-07-06 2001-01-22 Institut Pasteur Method of making and identifying attenuated microorganisms, compositions utilizing the sequences responsible for attenuation, and preparations containing attenuated microorganisms
WO2001019993A2 (en) * 1999-09-17 2001-03-22 University Of Maryland, Baltimore Virulence genes of m. marinum and m. tuberculosis
GB0014845D0 (en) * 2000-06-16 2000-08-09 Glaxo Group Ltd Vaccine
GB0028966D0 (en) * 2000-11-28 2001-01-10 Microbiological Res Authority Protection against mycobacterial infections
GB0124593D0 (en) * 2001-10-12 2001-12-05 Microbiological Res Authority Mycobacterial antigens expressed under high oxygen tension

Also Published As

Publication number Publication date
NZ519395A (en) 2004-04-30
IE20030431A1 (en) 2003-12-10
GB2389364A (en) 2003-12-10

Similar Documents

Publication Publication Date Title
GB0213622D0 (en) Vaccine Corporation
GB0202901D0 (en) Novel vaccine
GB0226722D0 (en) Vaccine
GB0225788D0 (en) Vaccine
IL173921A0 (en) Vaccine
GB0329146D0 (en) Vaccine
GB0225786D0 (en) Vaccine
GB0212046D0 (en) Vaccines
GB0228715D0 (en) Vaccine
GB0218921D0 (en) Novel vaccine
GB0305794D0 (en) Vaccine
GB0209878D0 (en) Vaccine
PL376534A1 (en) Vaccine
GB0330079D0 (en) Vaccine
GB0305793D0 (en) Vaccine
GB0212036D0 (en) Vaccines
GB0313064D0 (en) Mycobacterial vaccine
GB0206595D0 (en) Vaccine
IL156434A0 (en) Vaccine
GB0226179D0 (en) Vaccine
GB0223355D0 (en) Vaccine
GB0220211D0 (en) Vaccine
GB0216582D0 (en) Vaccine
GB0221689D0 (en) Vaccine
GB0223045D0 (en) Vaccine

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)